Key Points Immuron Engages Pullan Consulting to Advance IMM-529 Partnering Strategy Immuron is seeking a partner to support ...
Beyond rare diseases and oncology, Recursion’s pipeline includes two candidates. One is REC-3964, an oral, non-antibiotic small molecule designed to treat Clostridioides difficile (C. diff) by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results